Bare Financial Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.75K Buy
22
+3
+16% +$574 ﹤0.01% 874
2026
Q1
$3.48K Buy
19
+6
+46% +$1.11K ﹤0.01% 798
2025
Q4
$2.29K Buy
13
+3
+30% +$490 ﹤0.01% 817
2025
Q3
$1.4K Buy
+10
New +$1.35K ﹤0.01% 915

Other funds holding BIIB

Bare Financial Services's BIIB Position: Q2 2026 in Review

Bare Financial Services increased its Biogen (BIIB) stake by 16% in Q2 2026, buying an estimated $574 and bringing the position to 22 shares worth $4.75K. The position accounts for ﹤0.01% of the portfolio, ranked #874.

Bare Financial Services first reported a position in BIIB in Q3 2025 and has held it in 4 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Bare Financial Services held 22 shares of Biogen worth $4.75K as of Q2 2026.
  • Bare Financial Services bought 3 Biogen shares in Q2 2026, an estimated $574.
  • Biogen made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #874 holding.
  • Bare Financial Services first reported a position in Biogen in Q3 2025 and has held it in 4 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.